Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/08/2878154/0/en/Erasca-Reports-First-Quarter-2024-Business-Updates-and-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/07/2876689/0/en/Erasca-to-Present-at-the-Bank-of-America-Health-Care-Conference.html
https://www.globenewswire.com/news-release/2024/04/24/2869078/0/en/Erasca-Announces-Three-Presentations-at-the-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/28/2853682/0/en/Erasca-Announces-45-Million-Oversubscribed-Private-Placement-Financing.html
https://www.globenewswire.com/news-release/2024/03/27/2853585/0/en/Erasca-Reports-Fourth-Quarter-2023-and-Full-Year-2023-Business-Updates-and-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/14/2829047/0/en/Erasca-Announces-Two-Clinical-Trial-Collaboration-and-Supply-Agreements-for-Trametinib-to-Evaluate-Naporafenib-Combination-in-SEACRAFT-1-and-SEACRAFT-2-Trials.html
https://www.globenewswire.com//news-release/2024/02/01/2821947/0/en/Erasca-to-Present-at-the-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com//news-release/2024/01/03/2803224/0/en/Erasca-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/12/11/2793788/0/en/Erasca-Granted-FDA-Fast-Track-Designation-for-Pan-RAF-Inhibitor-Naporafenib-in-Patients-with-Advanced-NRAS-Mutated-Melanoma.html
https://www.globenewswire.com//news-release/2023/11/28/2786879/0/en/Erasca-Achieves-Key-Milestones-for-Naporafenib-and-ERAS-801-Programs-and-Extends-Cash-Runway.html